The Bank of Nova Scotia:企業のM&A・事業提携・投資動向

◆英語タイトル:The Bank of Nova Scotia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1440
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:264
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Bank of Nova Scotia – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s The Bank of Nova Scotia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by The Bank of Nova Scotia since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes The Bank of Nova Scotia’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by The Bank of Nova Scotia. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on The Bank of Nova Scotia’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by The Bank of Nova Scotia and its subsidiaries since 2007.
- Information about key financial and legal advisors for The Bank of Nova Scotia’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about The Bank of Nova Scotia’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 119
Corporate Venturing – Overview 119
Corporate Venturing – Deal reports 120
PARTNERSHIP 197
Partnership – Deal reports 197
CAPITAL RAISING 204
Capital Raising – Overview 204
Capital Raising – Deal reports 205
DIVESTMENTS 230
Divestments – Overview 230
Divestments – Deal reports 231
APPENDIX 254
Contact Us 254
About MarketLine Financial Deals Database 254
Deal Definition and Methodology 256
About MarketLine 263

List of Tables
Table 1: The Bank of Nova Scotia M&A volume and value trend (2014-YTD2018)
Table 2: The Bank of Nova Scotia M&A activity by geography (2014-YTD2018)
Table 3: The Bank of Nova Scotia corporate venturing volume and value trend (2014-YTD2018)
Table 4: The Bank of Nova Scotia corporate venturing by geography (2014-YTD2018)
Table 5: The Bank of Nova Scotia capital raising volume and value trend (2014-YTD2018)
Table 6: The Bank of Nova Scotia capital raising by deal type (2014-YTD2018)
Table 7: The Bank of Nova Scotia divestments volume and value trend (2014-YTD2018)
Table 8: The Bank of Nova Scotia divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: The Bank of Nova Scotia M&A volume and value trend (2014-YTD2018)
Figure 2: The Bank of Nova Scotia M&A activity by geography (2014-YTD2018)
Figure 3: The Bank of Nova Scotia corporate venturing volume and value trend (2014-YTD2018)
Figure 4: The Bank of Nova Scotia corporate venturing by geography (2014-YTD2018)
Figure 5: The Bank of Nova Scotia capital raising volume and value trend (2014-YTD2018)
Figure 6: The Bank of Nova Scotia capital raising by deal type (2014-YTD2018)
Figure 7: The Bank of Nova Scotia divestments volume and value trend (2014-YTD2018)
Figure 8: The Bank of Nova Scotia divestments by geography (2014-YTD2018)

★海外企業調査レポート[The Bank of Nova Scotia:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Austin Exploration Limited (AKK)-石油・ガス分野:企業M&A・提携分析
    Summary Austin Exploration Limited (Austin) is upstream oil and gas company that acquires, explores, develops, and produces oil and natural gas in the US. The company holds working interests in Colorado in the DJ Basin with the Niobrara and Pierre Shale as its primary oil and gas formations. It also …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Advanced Technology Company (ATC):企業の財務・戦略的SWOT分析
    Advanced Technology Company (ATC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Northern Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Northern Biologics Inc. (Northern Biologics) is a biotech company, which develops a portfolio of antibody therapies for treating cancer. The product pipeline of the company includes MSC-1, a first-in-class antibody that acts against leukemia inhibitory factor (LIF), which is a major immunosu …
  • Brickell Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Brickell Biotech Inc (Brickell Biotech) is a pharmaceutical company that develops differentiated therapeutics for the treatment of skin diseases. The company offers pipeline product candidates such as BBI-4000, BBI-5000, BBI-2000, BBI-3000 and BBI -6000. Its product candidate BBI-4000 is an …
  • KMG Chemicals Inc (KMG):企業の財務・戦略的SWOT分析
    KMG Chemicals Inc (KMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Science Applications International Corp:企業の戦略・SWOT・財務分析
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野:企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Plymouth Rock Assurance Corporation:企業の戦略・SWOT・財務情報
    Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Andrew Peller Limited:企業の戦略・SWOT・財務情報
    Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report Summary Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bactiguard Holding AB (BACTI B):医療機器:M&Aディール及び事業提携情報
    Summary Bactiguard Holding AB (Bactiguard) is a medical device manufacturer which develops and supplies infection protection solutions and antibiotics. The company’s product portfolio includes urinary catheters, foley catheters (BIP Foley catheters), endotracheal tubes and central venous catheters. …
  • EMS SA:企業の戦略的SWOT分析
    EMS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Graham Group Ltd:企業の戦略・SWOT・財務情報
    Graham Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Graham Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Applied Maths NV-医療機器分野:企業M&A・提携分析
    Summary Applied Maths NV (Applied Maths), a subsidiary of Biomerieux SA is a healthcare technology company that designs, develops and markets various bioscience software products. The company offers software products which include bionumerics, gelcompar, genemaths xt, kodon and bionumerics 2D. Its b …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Capital Lease Aviation Limited:企業の戦略・SWOT・財務分析
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆